Eaton Vance Tax-Advantaged Global Dividend Income Fund (ETG) vs abrdn Life Sciences Investors (HQL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
On valuation, abrdn Life Sciences Investors trades at a lower trailing P/E (2.6x vs 4.0x for Eaton Vance Tax-Advantaged Global Dividend Income Fund). abrdn Life Sciences Investors offers the higher dividend yield (10.96% vs 6.74%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ETG | HQL |
|---|---|---|
| Share price | $23.01 | $17.43 |
| Market cap | $1.76B | — |
| 1-day change | -0.26% | -0.74% |
| YTD return | — | +3.87% |
| 1-year return | — | +9.07% |
| 5-year return | — | -15.63% |
| P/E ratio (TTM) | 3.98 | 2.63 |
| EPS (TTM) | $5.78 | $6.64 |
| Dividend yield | 6.74% | 10.96% |
| Annual dividend | $1.55 | $1.91 |
| 52-week high | $24.71 | $22.67 |
| 52-week low | $19.34 | $15.66 |
| Distance from 52-week high | -6.88% | -23.11% |
| Average volume | 85.86K | 146.74K |
| Shares outstanding | 76.32M | — |
| Sector | Finance | Finance |
| Industry | Investment Managers | Investment Managers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Eaton Vance Tax-Advantaged Global Dividend Income Fund trades at a higher earnings multiple (4.0x vs 2.6x trailing P/E).
- abrdn Life Sciences Investors offers a meaningfully higher dividend yield (10.96% vs 6.74%).
About Eaton Vance Tax-Advantaged Global Dividend Income Fund
ETG stock →Eaton Vance Tax-Advantaged Global Dividend Income Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. The fund invests in public equity markets across the globe.
Finance · Investment Managers
About abrdn Life Sciences Investors
HQL stock →Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe.
Finance · Investment Managers
ETG vs HQL FAQ
Which has the lower P/E ratio, ETG or HQL?
HQL has the lower trailing P/E at 2.6, versus 4.0 for ETG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Eaton Vance Tax-Advantaged Global Dividend Income Fund or abrdn Life Sciences Investors?
abrdn Life Sciences Investors has the higher yield at 10.96%, compared with 6.74% for Eaton Vance Tax-Advantaged Global Dividend Income Fund.
Are Eaton Vance Tax-Advantaged Global Dividend Income Fund and abrdn Life Sciences Investors in the same industry?
Yes. Both are classified in the Investment Managers industry within the Finance sector.